Although inhibition of WIP1 by GSK2830371 is highly potent in vitro (IC50 = 6 nm) with good efficacy in WT P53 tumor cell lines, the compound exhibits poor pharmacokinetics with a short half-life in vivo (29). Here, TP53 is linked to neoplasm.